Brief: Synlogic Provides Corporate Update And Outlook For 2023

Synlogic

05/01/2023 12:18

Jan 5 (Reuters) - Synlogic Inc  SYBX.O :
    * SYNLOGIC PROVIDES CORPORATE UPDATE AND OUTLOOK FOR 2023
    * SYNLOGIC INC - RARE PEDIATRIC DISEASE DESIGNATION RECEIVED
FOR
SYNB1353 FOR HOMOCYSTINURIA (HCU)
    * SYNLOGIC INC - CASH RUNWAY EXPECTED INTO H2 2024
    * SYNLOGIC INC - PIVOTAL PHASE 3 FOR SYNB1934 IN
PHENYLKETONURIA
TO INITIATE IN H1 2023
    * SYNLOGIC INC - PIVOTAL PHASE 3 FOR SYNB1934 IN
PHENYLKETONURIA
(PKU) TO INITIATE IN H1 2023

Source text for Eikon:  ID:nGNX3CbfWF 
Further company coverage:  SYBX.O 
 ((Reuters.Briefs@thomsonreuters.com;))